FindTrial
Sign In

To study the effects of cholesterol lowering drugs (Atorvastatin and Rosuvastatin) on blood glucose levels.

To study the effects of Atorvastatin and Rosuvastatin on glycemic parameters of dyslipidemic patients.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013991
Enrollment
140
Registered
2018-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stable

Interventions

Intervention1: Rosuvastatin: To compare the effect of Rosuvastatin and Atorvastatin on glycemic parameters of the patient. Control Intervention1: Atorvastatin: To study the effect of Atorvastatin and

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: non diabetic, dyslipidemic patients with definite indication for starting hypolipidemic drugs

Exclusion criteria

Exclusion criteria: known case of diabetes mellitus, heart failure, hepatic ds, renal ds, pregnancy, psychotic ds, malignancy, septicemia, known case of HIV, HBV, HCV and immunocompromised patients

Design outcomes

Primary

MeasureTime frame
Fasting glucose levels, post prandial glucose levels, HbA1cTimepoint: 0, 12, 24 weeks—

Secondary

MeasureTime frame
Conversion to diabetesTimepoint: 6 months—

Countries

India

Contacts

Public ContactShamshi Azmi

Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University

ahmad.drjameel@gmail.com7906603082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026